Page Tools:

Dyslipidemia & Atherosclerosis Essentials 2009

Author(s): Christie M. Ballantyne, MD, Director, Section of Artherosclerosis, Professor of Medicine, Baylor College of Medicine, Houston, Texas
James H. O'Keefe Jr., MD, Professor of Medicine, University of Missouri at Kansas City, Mid-America Heart Institute, St. Lukes Hospital
Antonio M. Gotto Jr., MD, DPhil
Details:
  • ISBN-13: 9780763766092
  • Paperback    208 pages      © 2009
Price: International Sales $35.95 US List
Add to Cart

Overview

The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit!

Written by key opinion leaders in the field of cardiology, Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized.

Topics include:

  • Step-by-step guide to intensive LDL lowering
  • NCEP ATP III and AHA/ACC guideline Updates
  • Treatment of low HDL cholesterol and elevated triglyceride
  • 73 dyslipidemia trials and 17 drug summaries
     

ShowTable of Contents

Chapter  1  Overview of Atherosclerosis and Dyslipidemia
Chapter  2  Approach to Management of Dyslipidemia
Chapter  3  Treatment of Specific Dyslipidemia
Chapter  4  Dyslipidemia in Special Patient Populations
Chapter  5  Therapeutic Lifestyle Changes: Diet Modification
Chapter  6  Other Therapeutic Lifestyle Changes
Chapter  7  Overview of Drug Therapy for Dyslipidemia
Chapter  8  Drug Classes used to Treat Dyslipidemia
Chapter  9  Dyslipidemia Pitfalls
Chapter  10  Other Measures to Prevent Atherothrombosis
Chapter  11  Dyslipidemia and Cardiovascular Risk Reduction Trials
Chapter  12  Dyslipidemia Drug Summaries
Back to top

ShowAbout the Author(s)

Christie M. Ballantyne, MD-Director, Section of Artherosclerosis, Professor of Medicine, Baylor College of Medicine, Houston, Texas

Additional Titles by this Author

James H. O'Keefe Jr., MD-Professor of Medicine, University of Missouri at Kansas City, Mid-America Heart Institute, St. Lukes Hospital

James H. O'Keefe, Jr., M.D., is Director of Preventive Cardiology at the Mid America Heart Institute and Professor of Medicine at the University of Missouri in Kansas City. His postgraduate training included a cardiology fellowship at Mayo Clinic in Rochester, Minnesota. He has written 135 articles and 6 books on cardiovascular medicine, and he lectures extensively on the role of therapeutic lifestyle changes and drug therapy in cardiovascular risk reduction. He is actively involved in patient care. 

Additional Titles by this Author

Antonio M. Gotto Jr., MD, DPhil

Dr. Gotto is the Stephen and Suzanne Weiss Dean of Weill Medical College of Cornell University in New York, New York. He is also Professor of Medicine and Provost for Medical Affairs. He has been National President of the American Heart Association; President of the International Atherosclerosis Society; a member of the National Heart, Lung, and Blood Advisory Council and the National Diabetes Advisory Board; and a reviewer of the National Cholesterol Education Program's Third Report on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Dr. Gotto speaks nationally and internationally on cardiovascular disease and has contributed more than 500 scholarly articles and books. He and his associates were the first to achieve complete synthesis of a plasma apolipoprotein (apo C-I), and they also determined the complete cDNA and amino acid sequence of apo B-100, one of the largest proteins ever sequenced and a key protein in atherosclerosis.

Back to top